fda 503a bulks list peptides bpc-157 A majority of FDA's Pharmacy Compounding Advisory Committee voted in favor of allowing bulk compounding of #PCAC #peptides I just testified at an

I just testified at an FDA meeting on whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA Advisory Committee Meeting on Peptides Regional National Headlines

SKU: 48637153492 · From l2q2.es